VEGFA and myasthenia gravis: Therefore, we used the two-stage laser to establish a rat model of the subretinal fibrovascular membrane, combined with MG therapy on the basis of an anti-VEGF agent (ranibizumab), to observe the histomorphological therapeutic effect.